Alnylam

Earnings Estimates

Glossary »

Stock Information
Price (Prev Close) 78.46 Median Price Target 90.00
Price - 52 Week High 86.92 Diff from Prev Close 11.54
Price - 52 Week Low 31.38 % Difference 14.71%
Price Date (Latest) 07.20.2017    


Analyst Ratings
1-Strong Buy 2
2-Buy 7
3-Hold 8
4-Underperform 0
5-Sell 0

Mean Recommendation: 2.35



Reference Information
Last Actual (FY0) -4.79
FY0 End Date Dec '16
Ind. Annual Div. N/A
Hist (5 Yr) Growth % N/A
Hist (5 Yr) Stability % N/A
Yield (%) N/A


Analyst Forecasts
Last Month Revisions
Fiscal Period Mean High Low Median # of Estimates #Up #Down Mean % Change
Annual Dec '19 -3.04 2.10 -4.81 -3.38 13 4 0 -0.94 %
Annual Dec '18 -4.96 -3.10 -6.20 -5.15 16 3 1 -0.17 %
Annual Dec '17 -5.24 -4.41 -6.20 -5.23 17 5 0 N/A
Quarterly Jun '17 -1.21 -0.97 -1.46 -1.22 15 4 0 -1.23 %
Quarterly Sep '17 -1.30 -1.05 -1.70 -1.24 15 4 0 -1.93 %
Quarterly Dec '17 -1.38 -1.08 -1.80 -1.41 15 3 1 -1.59 %
Quarterly Mar '18 -1.37 -1.28 -1.46 -1.37 2 0 0 -  
Actuals
Fiscal Period   Reported EPS Mean Estimate Surprise % Change
Annual Dec '16 -4.79 -4.79 0.07 %
Quarterly Jun '16 -1.05 -1.24 15.38 %
Quarterly Sep '16 -1.21 -1.14 -6.36 %
Quarterly Dec '16 -1.32 -1.33 1.10 %
Quarterly Mar '17 -1.25 -1.26 0.73 %
Annual Dec '15 -3.45 -3.31 -4.20 %
Annual Dec '14 -4.85 -5.27 8.01 %

P/E Ratios
P/E Ratios Alnylam Pharmaceuticals, Inc. biotechnology Ind. Relative
FY0 N/A 53.22 N/A
FY1 N/A 56.74 N/A
FY2 N/A 38.48 N/A

EPS Growth Rates
Growth Rates Alnylam Pharmaceuticals, Inc. biotechnology Ind. Relative
FY1/FY0 N/A -3.04 N/A
FY2/FY1 N/A 43.81 N/A
FY3/FY2 N/A 46.62 N/A

Disclaimer: Mean earnings estimates are calculated by First Call based on their earnings projections made by the analysts who cover Alnylam Pharmaceuticals, Inc.. Please note that any opinions, estimates or forecasts regarding Alnylam Pharmaceuticals, Inc.'s performance made by these analysts (and therefore the average estimate numbers) are theirs and do not represent opinions, forecasts or predictions of Alnylam Pharmaceuticals, Inc. or its management. Alnylam Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Prices are in USD.